OakChart

Lite Strategy Inc

LITSHealthcare·Biotechnology·USA·Nano·NASD·Nov 11 • 3:33 PM ET

0.9859+0.0282 (2.94%)
2026-11-11 21:34 CET
Market cap
28.62 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-51.49 USD m
Free cash flow, TTM
-6.79 USD m
EPS diluted, TTM
-1.38
P/E
-
Compare

Price

LITS against its 20, 50 and 200-day averages
2050200
1.001.502.002.7M5.4MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26LITSclose 0.9920-day 1.1050-day 1.17200-day 1.080.9952w high52w low

55.2% under the 52-week high of 2.20 on 11 Nov 2025. 52-week low 0.69 on 11 Jun 2026. Last 15 sessions, 36.7% high to low

Volume 0.20× normal · the line is the 50-bar volume average

Profile

LITS
52-week range, 20% of the way up
0.692.20

Lite Strategy, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.

Employees5
IPODec 18, 2003
Beta0.23
ATR, 14d0.10
Rel volume0.20
Short float0.40%
Insider own1.62%
Inst own20.07%

Snapshot

6 groups

Valuation

Index-
Market Cap29.46M
Enterprise Value25.18M
Income-51.49M
Sales0.00M
Book/sh1.88
Cash/sh0.14
Dividend Est.-
Dividend TTM-
Dividend Ex-DateNov 16, 2023
Dividend Gr. 3/5Y- -
Payout-
Employees5
IPODec 18, 2003

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B0.53
P/C6.88
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio3.64
Current Ratio3.64
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.38
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y24.47% 29.72%
Sales past 3/5Y- -
EPS Y/Y TTM-5.00%
Sales Y/Y TTM-
EPS Q/Q491.01%
Sales Q/Q-
Earnings-
EPS/Sales Surpr.- -

Ownership

Insider Own1.62%
Insider Trans5.91%
Inst Own20.07%
Inst Trans0.01%
ROA-59.96%
ROE-60.95%
ROIC-90.82%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA20-10.59%
SMA50-15.94%
SMA200-8.63%
Trades-

Technical

Shs Outstand30.19M
Shs Float29.40M
Short Float0.40%
Short Ratio0.24
Short Interest0.12M
52W High2.20 -55.19%
52W Low0.69 43.13%
Volatility11.00% 7.69%
ATR (14)0.10
RSI (14)41.41
Beta0.23
Rel Volume0.20
Avg Volume504.23K
Volume96,436

Performance

Perf Week-8.71%
Perf Month-18.52%
Perf Quarter10.09%
Perf Half Y-16.45%
Perf YTD-25.31%
Perf Year-52.60%
Perf 3Y-82.20%
Perf 5Y-97.99%
Perf 10Y-96.18%
Recom2.33
Target Price22.67
Prev Close0.96
Price0.99
Change %2.94%

Analyst ratings

latest 10 of 18
DateActionAnalystRating changeTargetImplied
Jul 23, 2024DowngradeLLaidlawBuy → Hold
Mar 25, 2022DowngradeWWells FargoOverweight → Equal Weight$13 → $2+102.9%
Mar 25, 2022DowngradeSStifelBuy → Hold$6 → $2+102.9%
Mar 25, 2022DowngradeJJefferiesBuy → Hold$4 → $1+1.4%
Feb 03, 2022InitiatedJJefferiesBuy$4+305.7%
Sep 22, 2020InitiatedAAlliance Global PartnersBuy$9+812.9%
May 29, 2020InitiatedSSunTrustBuy$16+1,522.9%
Dec 20, 2018InitiatedHH.C. WainwrightBuy$10+914.3%
Dec 20, 2018InitiatedHH.C. WainwrightBuy
Jul 27, 2018UpgradeSStifelHold → Buy$2.50 → $7+610.0%

Peers

Mkt cap
TickerCompanyMkt cap
CYPHCypherpunk Technologies Inc214.99M
AVATAvalanche Treasury Corp48.53M
TAOXTAO Synergies Inc20.65M
HSDTSolana Co111.45M
SUIGSui Group Holdings Ltd70.12M
BTCSBTCS Inc49.65M
TONXTON Strategy Co213.68M
DFDVDeFi Development Corp127.58M
TWAVTaoWeave Inc4.73M
UPXIUpexi Inc61.73M

Insider trading

4 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Flynn James PDirectorJun 24 '26Buy0.8625,00021,388125,000Jun 25 04:30 PM
Schornstein Alexander10% OwnerDec 18 '25Sale1.37690,611946,1373,674,862Dec 22 04:15 PM
Flynn James PDirectorDec 19 '25Buy1.4070,00097,699100,000Dec 22 04:00 PM
Flynn James PDirectorNov 19 '25Buy1.8812,10022,77730,000Nov 20 04:00 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWCiShares Micro-Cap ETFAUM: 1.22B

News

latest 14 of 200
  • Lite Strategy Reports Fiscal 2027 First Quarter Financial Results (GlobeNewswire)
  • Lite Strategy Marks 15 Years of Litecoin with Launch of "Proof of Time" Public Industry Archive (GlobeNewswire)
  • Lite Strategy Reports Fiscal Year 2026 Financial Results (GlobeNewswire)
  • Lite Strategy to Present at the 28th Annual H.C. Wainwright Global Investment Conference in New York (GlobeNewswire)
  • Sellas Experimental Drug SLS009 Appears To Be Leading The CDK9 Race, Says Alliance Global Analyst Sees About 200% Upside Potential (Stocktwits)
  • Lite Strategy Repurchases 13% of Outstanding Shares Since December, Increasing Litecoin Backing Per Share (GlobeNewswire)
  • Can LitVM Bring Smart Contracts to Litecoin Without Changing Its Identity? (CCN)
  • Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam (GlobeNewswire)
  • Lite Strategy Leads Strategic Investment in LitVM (GlobeNewswire) -9.94%
  • Exclusive: Lite Strategy leads $1m investment in Litecoin Layer 2 platform LitVM (Investing.com)
  • Lite Strategy Reports Fiscal 2026 Third Quarter Results (GlobeNewswire) -5.60%
  • Lite Strategy Reports Fiscal 2026 Second Quarter Results (GlobeNewswire)
  • Lite Strategy Reports First Quarter Fiscal Year 2026 Results; Highlights Successful Launch of $100M Litecoin Treasury Strategy and Movement into Active Capital Market Operations (GlobeNewswire) -5.94%
  • Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation to Active Capital Market Operations (GlobeNewswire) +7.77%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2025Q32025-05-13-0.390--0.3900.00--
2025Q22025-02-12-0.400--0.4020.00--
2025Q12024-11-12-1.200--1.2020.00--
2024Q42024-09-19-2.760-1.407-2.7620.000.003
2024Q32024-05-09-1.370-1.487-1.3700.000.043
2024Q22024-02-13-1.660-1.413-1.6600.000.103
2024Q12023-11-098.460-1.7958.46165.300.002
2023Q42023-09-26-1.660-2.797-1.5051.470.623
2023Q32023-05-11-2.320-2.900-2.3175.890.354
2023Q22023-02-091.600-3.0331.53932.744.426
2023Q12022-11-14-2.400-3.350-2.4958.734.424
2022Q42022-09-08-4.200-3.850-2.413-0.604.788
2022Q32022-05-23-1.400-3.672-1.3119.693.448
2022Q22022-02-10-1.800-3.778-2.74918.225.269
2022Q12021-11-10-2.600-2.629-2.54013.3910.565
2021Q42021-09-02-1.004-3.371-2.18810.124.178

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY1.4000.0001.40023.2522.90
2018FY-19.400-14.680-19.4001.621.42
2019FY-4.800-13.200-15.0904.924.54
2020FY-10.200-1.050-10.10528.9148.48
2021FY-13.600-11.176-12.00325.5419.62
2022FY-10.000-9.114-9.98940.7041.79
2023FY-4.780-5.695-4.77848.8248.29
2024FY2.6703.6202.67065.3065.30
2025FY--6.280-2.393-0.00
2026FY--3.710-2.059-25.00
2027FY--1.560--25.00
2028FY--1.560--25.00

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2025Q2S2024-05-101000.000.000.00
2025Q2S2024-02-141000.000.000.00
2025Q2S2024-02-121000.000.000.00
2025Q2S2024-02-111000.000.000.00
2025Q2S2024-02-101000.000.000.00
2025Q2S2024-02-091000.000.000.00
2025Q2S2024-02-081000.000.000.00
2025Q2S2024-02-071000.000.000.00
2025Q2S2024-02-061000.000.000.00
2025Q2S2024-02-051000.000.000.00
2025Q2S2024-02-041000.000.000.00
2025Q2S2024-02-031000.000.000.00
2025Q2S2024-02-021000.000.000.00
2025Q2S2024-02-011000.000.000.00

Estimate history

EPS, annual-19.4-15.09-10.105-12.003-9.989-4.7782.668-2.393-2.059-1.3807
Period201820192020202120222023202420252026TTM
EPS, quarterly-1.202-0.402-0.386-0.403-0.124-0.824-0.664-0.3760.483
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Sales, annual1.6224.91528.91334.79640.69748.81665.297000
Period201820192020202120222023202420252026TTM
Sales, quarterly000000000
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Shares, annual3.523.6775.5765.6316.6586.6636.6636.66332.40730.192
Period201820192020202120222023202420252026MRQ
Shares, quarterly6.6636.6636.6636.66335.65536.64735.15632.40730.192
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Income statement, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue0.000.000.0065.3048.8240.7034.8028.914.92
Cost of Goods Sold Incl. D&A0.000.000.370.381.811.241.412.674.26
Gross Profit0.000.00-0.3764.9147.0039.4633.3926.240.65
Selling, General and Administrative Excl. Other11.4412.2717.0939.4780.17114.9593.8150.7846.90
Research and Development0.130.123.9216.5649.6585.6469.4034.0632.30
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-11.44-12.27-17.4525.44-33.16-75.48-60.42-24.54-46.24
Interest Expense0.000.000.000.000.000.000.000.000.00
Unusual Expense40.3059.150.0010.902.00-20.75-18.1222.87-27.63
Net Income Before Taxes-51.49-71.15-15.9517.78-31.84-54.45-41.31-46.02-16.82
Income Taxes0.000.000.000.000.000.000.010.000.00
Consolidated Net Income-51.49-71.15-15.9517.78-31.84-54.45-41.31-46.02-16.82
Net Income From Continuing Operations-51.49-71.15-15.9517.78-31.84-54.45-41.31-46.02-16.82
Net Income-51.49-71.15-15.9517.78-31.84-54.45-41.31-46.02-16.82
EPS (Recurring)-0.70-0.86-2.393.81-4.57-12.31-14.22-6.59-20.43
EPS (Basic, Before Extraordinaries)-1.38-2.06-2.392.67-4.78-8.75-7.34-10.10-4.73
EPS (Diluted)-1.38-2.06-2.392.67-4.78-9.99-12.00-10.10-15.09
EBITDA-11.44-12.27-17.0925.82-31.35-74.25-60.14-24.43-46.16
Non-Operating Income (Expense)0.250.271.513.243.320.281.001.401.79
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.121.29-0.142.283.598.357.484.965.18
Price To Earnings Ratio---0.74-----
Price To Sales Ratio---0.300.901.869.3813.0136.82
Gross Margin---99.4196.2896.9795.9590.7613.27
Operating Margin---38.96-67.94-185.48-173.65-84.88-940.90
Net Margin---27.23-65.22-133.80-118.73-159.15-342.20
Shares Outstanding30.1932.416.666.666.666.665.635.583.68
Market Capitalization28.6228.6216.4619.3934.0662.58249.31357.75138.43

Income statement, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q42025Q32025Q2
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.000.000.000.000.000.000.000.00
Gross Profit0.000.000.000.000.000.000.000.00
Selling, General and Administrative Excl. Other2.382.942.773.353.012.882.773.45
Research and Development0.020.040.030.050.010.080.370.31
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-2.38-2.94-2.77-3.35-3.01-2.88-2.77-3.45
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense-18.3210.1320.9827.510.730.000.00-
Net Income Before Taxes16.02-13.02-23.69-30.80-3.64-2.69-2.57-2.68
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income16.02-13.02-23.69-30.80-3.64-2.69-2.57-2.68
Net Income From Continuing Operations16.02-13.02-23.69-30.80-3.64-2.69-2.57-2.68
Net Income16.02-13.02-23.69-30.80-3.64-2.69-2.57-2.68
EPS (Recurring)0.10-0.17-0.25-0.31-0.11-0.40-0.39-0.40
EPS (Basic, Before Extraordinaries)0.48-0.38-0.66-0.82-0.12-0.40-0.39-0.40
EPS (Diluted)0.48-0.38-0.66-0.82-0.12-0.40-0.39-0.40
EBITDA-2.38-2.94-2.77-3.35-3.01-2.88-2.77-3.45
Non-Operating Income (Expense)0.080.050.050.060.100.190.200.77
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.120.500.270.230.280.080.020.10
Shares Outstanding30.1932.4135.1636.6535.666.666.666.66
Market Capitalization28.6231.3842.1848.5679.4716.4614.5916.39

Balance sheet, annual

Currency USD, millions
Metric2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments5.7118.0138.34100.69153.25153.43182.6374.49102.74
Short Term Receivables0.000.000.000.0910.047.5823.635.960.00
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets0.430.272.426.753.833.812.381.751.59
Total Current Assets6.1418.2940.77107.53167.13164.82208.6482.20104.33
Net Property, Plant & Equipment0.000.000.6113.2810.719.281.080.200.03
Total Investments and Advances1.000.000.000.000.000.000.000.000.00
Long-Term Note Receivable7.63--------
Intangible Assets27.270.000.000.000.000.000.000.260.30
Other Assets0.650.000.000.000.000.000.000.000.00
Total Assets42.6918.2941.38120.81177.84174.10209.7382.66104.66
Short Term Debt Incl. Current Port. of LT Debt0.000.000.001.430.870.930.000.000.00
Accounts Payable0.260.183.176.137.926.362.444.793.64
Other Current Liabilities0.811.185.1912.7815.6512.9320.879.514.24
Total Current Liabilities1.071.358.3620.3424.4420.2123.3014.307.88
Long Term Debt0.000.000.0011.308.777.370.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities0.000.000.0064.5592.2197.05108.2120.4346.31
Total Liabilities1.071.358.3696.19125.43124.63131.5134.7354.20
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity41.6216.9333.0224.6252.4149.4778.2247.9350.46
Total Shareholders Equity41.6216.9333.0224.6252.4149.4778.2247.9350.46
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity41.6216.9333.0224.6252.4149.4778.2247.9350.46
Total Liabilities & Stockholders Equity42.6918.2941.38120.81177.84174.10209.7382.66104.66
Book Value Per Share1.282.544.963.707.878.7814.0313.0314.33
Tangible Book Value Per Share0.442.544.963.707.878.7814.0312.9614.25
Full-Time Employees54284610276514032
Price to Book Ratio0.510.840.381.381.196.034.573.653.47
Return on Assets-233.37-53.4521.92-21.32-30.95-21.53-31.48-17.96-49.97
Return on Equity-243.02-63.8461.68-82.66-116.14-64.71-72.96-34.19-79.11
Return on Invested Capital-170.94-94.1853.84-88.63-89.00-72.69-58.83-35.09-79.41
Quick Ratio5.7413.504.885.296.848.158.955.7513.23
Current Ratio5.7413.504.885.296.848.158.955.7513.23

Cash flow, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-51.49-71.15-15.9517.78-31.84-54.45-41.31-46.02-16.82
Depreciation-0.000.370.381.811.240.280.110.08
Other Funds (Non Cash)44.0863.06-0.4215.432.49-12.40-7.8829.90-21.07
Funds from Operations-7.41-8.09-15.9933.59-27.54-65.62-48.91-16.01-37.81
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital0.62-1.03-4.85-84.28-24.9516.8816.9450.278.39
Cash from Operating Activities-6.79-9.12-20.84-50.68-52.48-48.75-31.9634.26-29.42
Capital Expenditures-107.91-100.000.00-0.01-0.04-0.48-0.71-0.89-0.22
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.510.000.000.000.000.000.00
Purchase or Sale of Investments99.00-1.0034.6449.1553.737.3725.42-105.4024.54
Purchase of Investments99.00-1.000.00-58.23-101.76-272.65-420.15-190.28-64.66
Sale Or Maturity of Investments0.000.0034.64107.38155.49280.02445.5784.8889.19
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources16.955.890.000.000.000.000.000.000.00
Cash from Investing Activities8.04-95.1135.1549.1453.696.8924.71-106.2924.32
Cash Dividends Paid0.000.000.00-11.660.000.000.000.000.00
Change in Capital Stock-7.0891.920.000.000.0049.053.4769.501.39
Repurchase of Common Pref Stock-7.29-4.890.000.000.000.000.000.000.00
Sale of Common Pref Stock0.2196.820.000.000.0049.053.4769.501.39
Proceedsfrom Stock Options92.4196.820.000.000.0052.333.2069.231.34
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.00-0.040.000.005.270.00
Other Financing Activities Uses0.000.000.000.00-0.040.000.000.000.00
Cash from Financing Activities-7.0891.920.00-11.66-0.0449.053.4774.781.39
Net Change in Cash-5.83-12.3014.31-13.201.177.20-3.792.74-3.72
Free Cash Flow-6.79-9.12-20.84-50.69-52.52-49.23-32.6733.36-29.64
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow-------11.27-
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q4
Cash & Short Term Investments4.285.717.548.7610.1118.01
Short Term Receivables0.000.000.000.000.000.00
Inventories0.000.000.000.000.000.00
Other Current Assets1.920.433.432.153.120.27
Total Current Assets6.206.1410.9710.9113.2418.29
Net Property, Plant & Equipment0.000.000.000.000.000.00
Total Investments and Advances1.041.000.0063.9799.370.00
Intangible Assets46.1827.2738.24--0.00
Other Assets0.620.650.680.700.730.00
Total Assets58.4042.6957.7982.94113.3418.29
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.00
Accounts Payable0.280.260.250.330.500.18
Other Current Liabilities1.430.810.700.760.561.18
Total Current Liabilities1.711.070.951.091.071.35
Long Term Debt0.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities1.711.070.951.091.071.35
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity56.7041.6256.8481.85112.2716.93
Total Shareholders Equity56.7041.6256.8481.85112.2716.93
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity56.7041.6256.8481.85112.2716.93
Total Liabilities & Stockholders Equity58.4042.6957.7982.94113.3418.29
Book Value Per Share1.881.281.622.233.152.54
Tangible Book Value Per Share0.350.440.532.233.152.54
Full-Time Employees-5---4
Price to Book Ratio0.510.570.520.420.950.84
Return on Assets-59.96-233.37-154.82-73.98-16.41-53.45
Return on Equity-60.95-243.02-159.26-76.38-16.88-63.84
Return on Invested Capital28.26-31.28-41.69-37.63-3.24-15.88
Quick Ratio3.645.7411.5310.0412.3913.50
Current Ratio3.645.7411.5310.0412.3913.50

Cash flow, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q4
Net Income16.02-13.02-23.69-30.80-3.64-2.69
Depreciation-0.000.000.000.000.00
Other Funds (Non Cash)-17.7311.3121.9328.571.250.08
Funds from Operations-1.71-1.71-1.76-2.23-2.39-2.61
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.470.550.240.30-2.120.15
Cash from Operating Activities-2.18-1.16-1.52-1.93-4.51-2.46
Capital Expenditures-7.910.00-100.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.00-1.00100.000.00-100.000.00
Purchase of Investments0.00-1.00100.000.00-100.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources11.063.232.100.570.000.00
Cash from Investing Activities3.152.232.100.57-100.000.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-2.40-2.90-1.790.0096.610.00
Repurchase of Common Pref Stock-2.40-2.90-1.79-0.200.000.00
Sale of Common Pref Stock0.000.000.000.2196.610.00
Proceedsfrom Stock Options0.0092.190.000.224.410.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-2.40-2.90-1.790.0196.610.00
Net Change in Cash-1.43-1.84-1.21-1.35-7.90-2.46
Free Cash Flow-2.18-1.16-1.52-1.93-4.51-2.46

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.40%0.1M29.4M480.00K
2026-10-150.36%0.1M29.9M471.35K
2026-09-300.62%0.2M30.0M402.62K
2026-09-150.25%0.1M33.5M255.27K
2026-08-310.76%0.3M33.5M270.08K
2026-08-140.47%0.2M33.5M324.60K
2026-07-310.34%0.1M33.5M372.79K
2026-07-150.40%0.1M29.9M393.45K
2026-06-300.47%0.1M29.9M399.26K
2026-06-150.33%0.1M29.9M359.89K
2026-05-290.51%0.2M30.2M321.29K
2026-05-150.26%0.1M30.2M290.92K
2026-04-300.30%0.1M32.2M294.75K
2026-04-150.20%0.1M32.2M330.05K
2026-03-310.29%0.1M32.3M390.30K
2026-03-130.29%0.1M32.3M534.17K
2026-02-270.37%0.1M32.3M535.30K
2026-02-131.00%0.3M32.3M582.86K
2026-01-300.62%0.2M32.6M587.27K
2026-01-150.35%0.1M32.6M631.79K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.000.000.750.4015.3203.000.000.878-0.0260.000
call2.500.000.050.014.4391,0860.000.174-0.0100.000
call4.000.005.000.006.0050.000.000.151-0.0120.000
call5.000.000.750.056.6012140.000.143-0.0130.000
call7.500.000.050.007.3250.000.000.133-0.0130.000
put1.000.000.750.0014.7080.000.00-0.122-0.0260.000
put2.501.151.901.6710.5302.000.00-0.824-0.0100.000
put4.000.805.500.000.0000.000.00-0.851-0.0120.000
put5.003.404.600.0016.3030.000.00-0.858-0.0120.000
put7.505.807.300.0022.1860.000.00-0.868-0.0130.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-038-KCurrent report2026-10-29SEC
2026-10-264Statement of changes in beneficial ownership of securities2025-07-22SEC
2026-10-264Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-264Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-264Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-264Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-06EFFECTEffectiveness filing by commission orderSEC
2026-09-28S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-09-28S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-09-2810-KAnnual report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-03SCHEDULE 13G/ASEC
2026-07-308-KCurrent report2026-07-30SEC
2026-07-248-KCurrent report2026-07-24SEC
2026-06-254Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-05-138-KCurrent report2026-05-13SEC
2026-05-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-02-178-KCurrent report2026-02-17SEC
2026-02-1710-QQuarterly report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-02-17SCHEDULE 13G/ASEC
2026-02-124Statement of changes in beneficial ownership of securities2026-02-12SEC
2026-02-128-KCurrent report2026-02-12SEC
2026-01-27DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2025-12-30ARSAnnual report to security holders. 2025-06-30SEC
2025-12-30DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2025-12-30DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342025-12-30SEC
2025-12-308-KCurrent report2025-12-23SEC
2025-12-224Statement of changes in beneficial ownership of securities2025-12-19SEC
2025-12-22SCHEDULE 13G/ASEC
2025-12-224Statement of changes in beneficial ownership of securities2025-12-18SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-0621.39K100
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-1297.70K1946.14K1
2025-1122.78K100

Institutional holders

Manager% owned
RENAISSANCE TECHNOLOGIES LLC3.67%
VANGUARD CAPITAL MANAGEMENT LLC3.00%
RLH Capital LLC2.65%
TWO SIGMA INVESTMENTS, LP1.64%
GEODE CAPITAL MANAGEMENT, LLC1.20%
CITADEL ADVISORS LLC1.05%
BlackRock, Inc.0.81%
MARSHALL WACE, LLP0.68%
VANGUARD FIDUCIARY TRUST CO0.57%
JANE STREET GROUP, LLC0.57%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND1.94%
VANGUARD EXTENDED MARKET INDEX FUND1.06%
Fidelity Extended Market Index Fund0.48%
iShares Micro-Cap ETF0.33%
Fidelity Total Market Index Fund0.16%
Fidelity Series Total Market Index Fund0.15%
Nomura Healthcare Fund0.09%
Fidelity Nasdaq Composite Index Fund0.04%
1290 VT Micro Cap Portfolio0.02%
Blackstone Alternative Multi-Strategy Fund0.01%

OakChart. LITS. Cached 15 minutes.